Adverse event profile and associated factors following surgical voluntary medical male circumcision in two regions of Namibia, 2015-2018.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 23 06 2021
accepted: 30 09 2021
entrez: 20 10 2021
pubmed: 21 10 2021
medline: 26 11 2021
Statut: epublish

Résumé

Monitoring clinical safety of voluntary medical male circumcision (VMMC) is critical to minimize risk as VMMC programs for HIV prevention are scaled. This cross-sectional analysis describes the adverse event (AE) profile of a large-scale, routine VMMC program and identifies factors associated with the development, severity, and timing of AEs to provide recommendations for program quality improvement. From 2015-2018 there were 28,990 circumcisions performed in International Training and Education Center for Health (I-TECH) supported regions of Namibia in collaboration with the Ministry of Health and Social Services. Two routine follow-up visits after VMMC were scheduled to identify clients with AEs. Summary statistics were used to describe characteristics of all VMMC clients and the subset who experienced an AE. We used chi-square tests to evaluate associations between AE timing, patient age, and other patient and AE characteristics. We used a logistic regression model to explore associations between patient characteristics and AE severity. Of the 498 clients with AEs (AE rate of 1.7%), 40 (8%) occurred ≤2 days, 262 (53%) occurred 3-7 days, 161 (32%) between day 8 and 14, and 35 (7%) were ≥15 days post-VMMC. Early AEs (on or before day 2) tended to be severe and categorized as bleeding, while infections were the most common AEs occurring later (p<0.001). Younger clients (aged 10-14 years) experienced more infections, whereas older clients experienced more bleeding (p<0.001). Almost 40% of AEs occurred after the second follow-up visit, of which 179 (91%) were infections. Improvements in pre-surgical and post-surgical counselling and post-operative educational materials encouraging clients to seek care at any time, adoption of alternative follow-up methods, and the addition of a third follow-up visit may improve outcomes for patients. Enhancing post-surgical counselling and emphasizing wound care for younger VMMC clients and their caregivers could help mitigate elevated risk of infection.

Identifiants

pubmed: 34669709
doi: 10.1371/journal.pone.0258611
pii: PONE-D-21-20649
pmc: PMC8528325
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0258611

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Infect Dis. 2018 Apr 3;66(suppl_3):S161-S165
pubmed: 29617774
PLoS One. 2015 Sep 25;10(9):e0138755
pubmed: 26405786
J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):16-23
pubmed: 31809358
PLoS One. 2013 May 22;8(5):e63134
pubmed: 23717402
BMC Health Serv Res. 2019 Nov 21;19(1):855
pubmed: 31752838
PLoS One. 2017 Nov 14;12(11):e0186831
pubmed: 29136009
Glob Health Sci Pract. 2014 Jan 09;2(1):93-102
pubmed: 25276565
PLoS One. 2018 Sep 27;13(9):e0205113
pubmed: 30261043
J Int AIDS Soc. 2014 Nov 17;17:19275
pubmed: 25406951
Bull World Health Organ. 2012 Oct 1;90(10):773-81
pubmed: 23109745
BMC Health Serv Res. 2016 Feb 17;16:61
pubmed: 26888178
PLoS One. 2014 Aug 21;9(8):e100008
pubmed: 25144194
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S189-S197
pubmed: 29617779
PLoS One. 2019 Jun 10;14(6):e0218137
pubmed: 31181096
PLoS One. 2017 Nov 7;12(11):e0185904
pubmed: 29112959
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S49-55
pubmed: 27331590
MMWR Morb Mortal Wkly Rep. 2013 Nov 29;62(47):953-7
pubmed: 24280914
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
PLoS One. 2015 Sep 14;10(9):e0137376
pubmed: 26367187
PLoS One. 2014 May 01;9(5):e95357
pubmed: 24788898
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S198-S204
pubmed: 29617772
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S229-S235
pubmed: 29617777
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S43-8
pubmed: 27331589
J Acquir Immune Defic Syndr. 2015 May 1;69(1):e13-23
pubmed: 25942466
PLoS One. 2014 Jan 28;9(1):e86631
pubmed: 24489754
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S173-S182
pubmed: 29617775
AIDS. 2017 Jul 1;31 Suppl 3:S233-S241
pubmed: 28665881
J Int AIDS Soc. 2019 Jul;22(7):e25369
pubmed: 31368235

Auteurs

Gillian O'Bryan (G)

Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Seattle, WA, United States of America.
Department of Global Health, University of Washington, Seattle, WA, United States of America.

Caryl Feldacker (C)

Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Seattle, WA, United States of America.
Department of Global Health, University of Washington, Seattle, WA, United States of America.

Alison Ensminger (A)

Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Seattle, WA, United States of America.
Department of Global Health, University of Washington, Seattle, WA, United States of America.

Magdaleena Nghatanga (M)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Windhoek, Namibia.

Laura Brandt (L)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Windhoek, Namibia.

Mark Shepard (M)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Windhoek, Namibia.

Idel Billah (I)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Windhoek, Namibia.

Mekondjo Aupokolo (M)

Directorate of Special Programs-Ministry of Health and Social Services, Windhoek, Namibia.

Assegid Tassew Mengistu (AT)

Directorate of Special Programs-Ministry of Health and Social Services, Windhoek, Namibia.

Norbert Forster (N)

Department of Global Health, University of Washington, Seattle, WA, United States of America.
Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Windhoek, Namibia.

Brigitte Zemburuka (B)

Centers for Disease Control and Prevention (CDC/DDPHSIS/CGH/DGHT), Windhoek, Namibia.

Edwin Sithole (E)

Centers for Disease Control and Prevention (CDC/DDPHSIS/CGH/DGHT), Windhoek, Namibia.

Gram Mutandi (G)

Centers for Disease Control and Prevention (CDC/DDPHSIS/CGH/DGHT), Windhoek, Namibia.

Scott Barnhart (S)

Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Seattle, WA, United States of America.
Department of Medicine, University of Washington, Seattle, WA, United States of America.

Gabrielle O'Malley (G)

Department of Global Health, International Training and Education Center for Health (I-TECH), University of Washington, Seattle, WA, United States of America.
Department of Global Health, University of Washington, Seattle, WA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH